. .treatment, update. World Health Organization; 2022, : .
Berhan A,Almaw A,Solomon Y,Legese B,Damtie S,Erkihun M .2023 .Tuberculosis treatment outcome and associated factors among tuberculosis patients linked to tuberculosis treatment clinics in Ethiopia, 2023: A multi-center retrospective study. Infect Drug Resist, 10 : 3367-78.
Amkongo M,Mitonga HK,Alfeus A,Shipingana LN,Keendjele T,Eelu H .2023 .Factors associated with the unsuccessful TB treatment outcomes in the northern regions of Namibia: A mixed methods study. BMC Infect Dis, 10 : 342.
Gill CM,Dolan L,Piggott LM,McLaughlin AM .2022 .New developments in tuberculosis diagnosis and treatment. Breathe (She ), 10(1) : 0149-2021.
Lim WS,Avery A,Kon OM,Dedicoat M .2023 .Anti-tuberculosis drug-induced liver injury. BMJ, 10 : .
Lewis JH,Korkmaz SY,Rizk CA,Copeland MJ CA .2024 .Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis. Expert Opin Drug Saf, 2399074(9) : 1093-107.
Zhuang X,Li L,Liu T,Zhang R,Yang P,Wang X .2022 .Mechanisms of isoniazid and rifampicin-induced liver injury and the e ects of natural medicinal ingredients: A review. Front Pharmacol, 103 : 1037814.
Khan S,Mandal RK,Elasbali AM,Dar SA,Jawed A,Wahid M .2019 .Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: Trial sequence meta-analysis as evidence. Biosci Rep, 10(1) : .
Poudel AN,Zhu S,Cooper N,Little P,Tarrant C,Hickman M .2023 .The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLoS One, 0285170(5) : .
Nelson RE,Hat eld KM,Wolford H,Samore MH,Scott RD,Reddy SC .2021 .National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States. Clin Infect Dis, 10(Suppl 1) : S17-26.
Fei M,Xie Q,Zou Y,He R,Zhang Y,Wang J .2016 .Alphalipoic acid protects mice against concanavalin A-induced hepatitis by modulating cytokine secretion and reducing reactive oxygen species generation. Int Immunopharmacol, 03 : 53-60.
Tanaka Y,Kaibori M,Miki H,Nakatake R,Tokuhara K,Nishizawa M .2014 .Alpha-lipoic acid exerts a liver-protective e ect in acute liver injury ratsJ. Surg Res2015, 08(2) : 675-83.
Wessam H,Ezzeddin S,Wessam H,Somaia A,Adel B,Naglaa A .2013 .Possible protection against isoniaizd induced hepatotoxicity by certain natural agents. Int J Pharm Res Bio-Sci, 2 : 345-61.
Amara IB,Soudani N,Troudi A,Bouaziz H,Boudawara T,Zeghal N. .2010 .Antioxidant e ect of vitamin E and selenium on hepatotoxicity induced by dimethoate in female adult rats. Ecotoxicol Environ Saf, 11(4) : 811-9.
Metushi IG,Nakagawa T,Uetrecht J .2012 .Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats. Chem Res Toxicol, 10(11) : 2567-76.
Iluz-Freundlich D,Zhang M,Uhanova J,Minuk GY .2019 .The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease. Ann Hepatol, 08(2) : 204-8.
Eminzade S,Uras F,Izzettin FV .2008 .Silymarin protects liver against toxic e ects of anti-tuberculosis drugs in experimental animals. Nutr, 10 : 1743.
Sharma S,Anand A,Verma N,Sharma V,Bhatia A,Patil AN . .Pharmacokinetic assessment of isoniazid and acetylisoniazid in carbon tetrachloride-induced liver injury model in wistar rats. J Pharm Bioallied, 10(3) : 23-45.